The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anti-fungal Drugs Market Research Report 2025
Synopsis
Antifungal drugs are used to treat fungal infections, which most commonly affect your skin, hair and nails.
The global Anti-fungal Drugs market was valued at US$ 1720.6 million in 2023 and is anticipated to reach US$ 2097.9 million by 2030, witnessing a CAGR of 2.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti-fungal Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-fungal Drugs.
Report Scope
The Anti-fungal Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-fungal Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-fungal Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Astellas Pharma
Bayer
GlaxoSmithKline
Glenmark
Kramer Laboratories
Merck
Novartis
Pfizer
SCYNEXIS
Sanofi
Gilead Science
Enzon Pharmaceuticals
Segment by Type
Powder
Ointment
Tablet
Other
Segment by Application
Hospital
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-fungal Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Antifungal drugs are used to treat fungal infections, which most commonly affect your skin, hair and nails.
The global Anti-fungal Drugs market was valued at US$ 1720.6 million in 2023 and is anticipated to reach US$ 2097.9 million by 2030, witnessing a CAGR of 2.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti-fungal Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-fungal Drugs.
Report Scope
The Anti-fungal Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-fungal Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-fungal Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Astellas Pharma
Bayer
GlaxoSmithKline
Glenmark
Kramer Laboratories
Merck
Novartis
Pfizer
SCYNEXIS
Sanofi
Gilead Science
Enzon Pharmaceuticals
Segment by Type
Powder
Ointment
Tablet
Other
Segment by Application
Hospital
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-fungal Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-fungal Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Powder
1.2.3 Ointment
1.2.4 Tablet
1.2.5 Other
1.3 Market by Application
1.3.1 Global Anti-fungal Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-fungal Drugs Market Perspective (2019-2030)
2.2 Anti-fungal Drugs Growth Trends by Region
2.2.1 Global Anti-fungal Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Anti-fungal Drugs Historic Market Size by Region (2019-2024)
2.2.3 Anti-fungal Drugs Forecasted Market Size by Region (2025-2030)
2.3 Anti-fungal Drugs Market Dynamics
2.3.1 Anti-fungal Drugs Industry Trends
2.3.2 Anti-fungal Drugs Market Drivers
2.3.3 Anti-fungal Drugs Market Challenges
2.3.4 Anti-fungal Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-fungal Drugs Players by Revenue
3.1.1 Global Top Anti-fungal Drugs Players by Revenue (2019-2024)
3.1.2 Global Anti-fungal Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Anti-fungal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-fungal Drugs Revenue
3.4 Global Anti-fungal Drugs Market Concentration Ratio
3.4.1 Global Anti-fungal Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-fungal Drugs Revenue in 2023
3.5 Anti-fungal Drugs Key Players Head office and Area Served
3.6 Key Players Anti-fungal Drugs Product Solution and Service
3.7 Date of Enter into Anti-fungal Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-fungal Drugs Breakdown Data by Type
4.1 Global Anti-fungal Drugs Historic Market Size by Type (2019-2024)
4.2 Global Anti-fungal Drugs Forecasted Market Size by Type (2025-2030)
5 Anti-fungal Drugs Breakdown Data by Application
5.1 Global Anti-fungal Drugs Historic Market Size by Application (2019-2024)
5.2 Global Anti-fungal Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Anti-fungal Drugs Market Size (2019-2030)
6.2 North America Anti-fungal Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Anti-fungal Drugs Market Size by Country (2019-2024)
6.4 North America Anti-fungal Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-fungal Drugs Market Size (2019-2030)
7.2 Europe Anti-fungal Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Anti-fungal Drugs Market Size by Country (2019-2024)
7.4 Europe Anti-fungal Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-fungal Drugs Market Size (2019-2030)
8.2 Asia-Pacific Anti-fungal Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Anti-fungal Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Anti-fungal Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-fungal Drugs Market Size (2019-2030)
9.2 Latin America Anti-fungal Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Anti-fungal Drugs Market Size by Country (2019-2024)
9.4 Latin America Anti-fungal Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-fungal Drugs Market Size (2019-2030)
10.2 Middle East & Africa Anti-fungal Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Anti-fungal Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Anti-fungal Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Anti-fungal Drugs Introduction
11.1.4 Abbott Laboratories Revenue in Anti-fungal Drugs Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Detail
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Anti-fungal Drugs Introduction
11.2.4 Astellas Pharma Revenue in Anti-fungal Drugs Business (2019-2024)
11.2.5 Astellas Pharma Recent Development
11.3 Bayer
11.3.1 Bayer Company Detail
11.3.2 Bayer Business Overview
11.3.3 Bayer Anti-fungal Drugs Introduction
11.3.4 Bayer Revenue in Anti-fungal Drugs Business (2019-2024)
11.3.5 Bayer Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Anti-fungal Drugs Introduction
11.4.4 GlaxoSmithKline Revenue in Anti-fungal Drugs Business (2019-2024)
11.4.5 GlaxoSmithKline Recent Development
11.5 Glenmark
11.5.1 Glenmark Company Detail
11.5.2 Glenmark Business Overview
11.5.3 Glenmark Anti-fungal Drugs Introduction
11.5.4 Glenmark Revenue in Anti-fungal Drugs Business (2019-2024)
11.5.5 Glenmark Recent Development
11.6 Kramer Laboratories
11.6.1 Kramer Laboratories Company Detail
11.6.2 Kramer Laboratories Business Overview
11.6.3 Kramer Laboratories Anti-fungal Drugs Introduction
11.6.4 Kramer Laboratories Revenue in Anti-fungal Drugs Business (2019-2024)
11.6.5 Kramer Laboratories Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Anti-fungal Drugs Introduction
11.7.4 Merck Revenue in Anti-fungal Drugs Business (2019-2024)
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Anti-fungal Drugs Introduction
11.8.4 Novartis Revenue in Anti-fungal Drugs Business (2019-2024)
11.8.5 Novartis Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Anti-fungal Drugs Introduction
11.9.4 Pfizer Revenue in Anti-fungal Drugs Business (2019-2024)
11.9.5 Pfizer Recent Development
11.10 SCYNEXIS
11.10.1 SCYNEXIS Company Detail
11.10.2 SCYNEXIS Business Overview
11.10.3 SCYNEXIS Anti-fungal Drugs Introduction
11.10.4 SCYNEXIS Revenue in Anti-fungal Drugs Business (2019-2024)
11.10.5 SCYNEXIS Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Detail
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Anti-fungal Drugs Introduction
11.11.4 Sanofi Revenue in Anti-fungal Drugs Business (2019-2024)
11.11.5 Sanofi Recent Development
11.12 Gilead Science
11.12.1 Gilead Science Company Detail
11.12.2 Gilead Science Business Overview
11.12.3 Gilead Science Anti-fungal Drugs Introduction
11.12.4 Gilead Science Revenue in Anti-fungal Drugs Business (2019-2024)
11.12.5 Gilead Science Recent Development
11.13 Enzon Pharmaceuticals
11.13.1 Enzon Pharmaceuticals Company Detail
11.13.2 Enzon Pharmaceuticals Business Overview
11.13.3 Enzon Pharmaceuticals Anti-fungal Drugs Introduction
11.13.4 Enzon Pharmaceuticals Revenue in Anti-fungal Drugs Business (2019-2024)
11.13.5 Enzon Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Anti-fungal Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Powder
Table 3. Key Players of Ointment
Table 4. Key Players of Tablet
Table 5. Key Players of Other
Table 6. Global Anti-fungal Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Anti-fungal Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Anti-fungal Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Anti-fungal Drugs Market Share by Region (2019-2024)
Table 10. Global Anti-fungal Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Anti-fungal Drugs Market Share by Region (2025-2030)
Table 12. Anti-fungal Drugs Market Trends
Table 13. Anti-fungal Drugs Market Drivers
Table 14. Anti-fungal Drugs Market Challenges
Table 15. Anti-fungal Drugs Market Restraints
Table 16. Global Anti-fungal Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Anti-fungal Drugs Market Share by Players (2019-2024)
Table 18. Global Top Anti-fungal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-fungal Drugs as of 2023)
Table 19. Ranking of Global Top Anti-fungal Drugs Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Anti-fungal Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Anti-fungal Drugs Product Solution and Service
Table 23. Date of Enter into Anti-fungal Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anti-fungal Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Anti-fungal Drugs Revenue Market Share by Type (2019-2024)
Table 27. Global Anti-fungal Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Anti-fungal Drugs Revenue Market Share by Type (2025-2030)
Table 29. Global Anti-fungal Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Anti-fungal Drugs Revenue Market Share by Application (2019-2024)
Table 31. Global Anti-fungal Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Anti-fungal Drugs Revenue Market Share by Application (2025-2030)
Table 33. North America Anti-fungal Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Anti-fungal Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Anti-fungal Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Anti-fungal Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Anti-fungal Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Anti-fungal Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Anti-fungal Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Anti-fungal Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Anti-fungal Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Anti-fungal Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Anti-fungal Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Anti-fungal Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Anti-fungal Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Anti-fungal Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Anti-fungal Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 48. Abbott Laboratories Company Detail
Table 49. Abbott Laboratories Business Overview
Table 50. Abbott Laboratories Anti-fungal Drugs Product
Table 51. Abbott Laboratories Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
Table 52. Abbott Laboratories Recent Development
Table 53. Astellas Pharma Company Detail
Table 54. Astellas Pharma Business Overview
Table 55. Astellas Pharma Anti-fungal Drugs Product
Table 56. Astellas Pharma Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
Table 57. Astellas Pharma Recent Development
Table 58. Bayer Company Detail
Table 59. Bayer Business Overview
Table 60. Bayer Anti-fungal Drugs Product
Table 61. Bayer Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
Table 62. Bayer Recent Development
Table 63. GlaxoSmithKline Company Detail
Table 64. GlaxoSmithKline Business Overview
Table 65. GlaxoSmithKline Anti-fungal Drugs Product
Table 66. GlaxoSmithKline Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
Table 67. GlaxoSmithKline Recent Development
Table 68. Glenmark Company Detail
Table 69. Glenmark Business Overview
Table 70. Glenmark Anti-fungal Drugs Product
Table 71. Glenmark Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
Table 72. Glenmark Recent Development
Table 73. Kramer Laboratories Company Detail
Table 74. Kramer Laboratories Business Overview
Table 75. Kramer Laboratories Anti-fungal Drugs Product
Table 76. Kramer Laboratories Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
Table 77. Kramer Laboratories Recent Development
Table 78. Merck Company Detail
Table 79. Merck Business Overview
Table 80. Merck Anti-fungal Drugs Product
Table 81. Merck Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
Table 82. Merck Recent Development
Table 83. Novartis Company Detail
Table 84. Novartis Business Overview
Table 85. Novartis Anti-fungal Drugs Product
Table 86. Novartis Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
Table 87. Novartis Recent Development
Table 88. Pfizer Company Detail
Table 89. Pfizer Business Overview
Table 90. Pfizer Anti-fungal Drugs Product
Table 91. Pfizer Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
Table 92. Pfizer Recent Development
Table 93. SCYNEXIS Company Detail
Table 94. SCYNEXIS Business Overview
Table 95. SCYNEXIS Anti-fungal Drugs Product
Table 96. SCYNEXIS Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
Table 97. SCYNEXIS Recent Development
Table 98. Sanofi Company Detail
Table 99. Sanofi Business Overview
Table 100. Sanofi Anti-fungal Drugs Product
Table 101. Sanofi Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
Table 102. Sanofi Recent Development
Table 103. Gilead Science Company Detail
Table 104. Gilead Science Business Overview
Table 105. Gilead Science Anti-fungal Drugs Product
Table 106. Gilead Science Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
Table 107. Gilead Science Recent Development
Table 108. Enzon Pharmaceuticals Company Detail
Table 109. Enzon Pharmaceuticals Business Overview
Table 110. Enzon Pharmaceuticals Anti-fungal Drugs Product
Table 111. Enzon Pharmaceuticals Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
Table 112. Enzon Pharmaceuticals Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-fungal Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Anti-fungal Drugs Market Share by Type: 2023 VS 2030
Figure 3. Powder Features
Figure 4. Ointment Features
Figure 5. Tablet Features
Figure 6. Other Features
Figure 7. Global Anti-fungal Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Anti-fungal Drugs Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Online Pharmacy Case Studies
Figure 12. Anti-fungal Drugs Report Years Considered
Figure 13. Global Anti-fungal Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Anti-fungal Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Anti-fungal Drugs Market Share by Region: 2023 VS 2030
Figure 16. Global Anti-fungal Drugs Market Share by Players in 2023
Figure 17. Global Top Anti-fungal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-fungal Drugs as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Anti-fungal Drugs Revenue in 2023
Figure 19. North America Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Anti-fungal Drugs Market Share by Country (2019-2030)
Figure 21. United States Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Anti-fungal Drugs Market Share by Country (2019-2030)
Figure 25. Germany Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Anti-fungal Drugs Market Share by Region (2019-2030)
Figure 33. China Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Anti-fungal Drugs Market Share by Country (2019-2030)
Figure 41. Mexico Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Anti-fungal Drugs Market Share by Country (2019-2030)
Figure 45. Turkey Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Abbott Laboratories Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
Figure 48. Astellas Pharma Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
Figure 49. Bayer Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
Figure 51. Glenmark Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
Figure 52. Kramer Laboratories Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
Figure 53. Merck Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
Figure 54. Novartis Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
Figure 55. Pfizer Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
Figure 56. SCYNEXIS Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
Figure 57. Sanofi Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
Figure 58. Gilead Science Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
Figure 59. Enzon Pharmaceuticals Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
